USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Technological Innovations and Growth Opportunities in Diagnostic Biochips
Rapidly Evolving Microfluidic Biochips Enable Low-cost Point-of-care Diagnostics
13-Oct-2022
Global
Technology Research
$4,950.00
Special Price $4,207.50 save 15 %
Biological systems are complex and involve several biological reactions and biomolecules. Understanding the biological reactions and identifying the associated biomolecules will help in the development of accurate diagnostics and aid precision medicine. Yet the high number of molecules often requires multiple tests or bulky instruments. To overcome this need, diagnostic biochip technology offers a miniaturized multiplexing sensing platform. A biochip is a solid substrate with a multitude of miniaturized test sites that have immobilized probes to capture and detect the target biomolecules. While biochips can have several applications, current research focuses on diagnostic biochips.
The huge demand for precision medicine and low-cost point-of-care diagnostic platforms will drive the market. However, key players must focus on reducing the costs of DNA and protein biochips, meeting regulatory standards, and increasing awareness among users.
The global diagnostic biochips industry is advancing, offering new fluidic control technologies, probe immobilization techniques, signal detection technologies, and data analytics. As they can detect different kinds of biomolecules, innovative diagnostic biochips provide growth opportunities for genetic testing, cancer diagnostics and therapy, infectious diseases management, chronic disease management, allergy panel testing, and drug testing. This study focuses on DNA biochips, protein biochips, and microfluidic biochips.
The key elements of this analysis include an overview of the global diagnostic biochips industry supported by the following:
• Technology advantages and disadvantages
• Industry growth drivers and restraints
• Key participants in different industry segments
• Technology roadmap
• SWOT analysis of diagnostic biochips
• Adoption, funding, and M&A trends
• Impact of the different technology segments
• Patent filing trends
• Growth opportunities for key companies
Biological systems are complex and involve several biological reactions and biomolecules. Understanding the biological reactions and identifying the biomolecules involved will help in the development of accurate diagnostics and aid precision medicine. As a large number of molecules are involved, multiple tests or bulky instruments may be required. Diagnostic biochip technology caters to the need of a miniaturized multiplexing sensing platform. A biochip is a solid substrate with a multitude of miniaturized test sites with immobilized probes that capture and detect the target biomolecules. While biochips can have several applications, the current research focuses on diagnostic biochips. There is a huge demand for precision medicine and low-cost point of care diagnostic platforms which will push the market forward. But the key players need to focus on reducing the costs of DNA and protein biochips, meeting regulatory standards and increasing awareness among users. Diagnostic biochips industry is advancing with new fluidic control technologies, probe immobilization techniques, signal detection technologies and data analytics. As they can detect all different kinds of biomolecules, the diagnostic biochip technology innovations provide growth opportunities for genetic testing, cancer diagnostics and therapy, infectious diseases management, chronic disease management, allergy panel testing and drug testing markets. The study focuses on DNA biochips, protein biochips and microfluidic biochips. The study provides an overview for the diagnostic biochips technology, their advantages and disadvantages. The drivers and restraints to the growth of the diagnostic biochips industry are discussed. The key participants in the different segments of the industry and the technologies employed are explored. The technology roadmap and the SWOT analysis of diagnostic biochips is provided. The adoption, funding and M&A trends, and the impact of the different technology segments have been analyzed. The growth opportunities for the key companies and the patent filing trend in the industry have also been put forth.
Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Diagnostic Biochips Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology
Diagnostic Biochips for Miniature and Multiplexing Biosensing Devices
Diagnostic Biochips Are Advancing with New Microarray Formats and Fabrication Technologies
Biochips as Miniature Devices Enable High-throughput Testing
Biochips Have a Multitude of Applications
Segmentation
Increasing Demand for Personalized Medicine as a Growth Driver for Diagnostic Biochips Industry
High Costs as a Growth Restraint for Diagnostic Biochips Industry
Diagnostic Biochips Industry as a Growing and Fragmented Market
Scope of Analysis
DNA Biochips Enabling Detection of Genetic Biomarkers of Disease
Emerging DNA Biochip Fabrication Technologies Aiming for Low Device Costs
Diagnostic DNA Biochips Have High Impact on Biomarkers Discovery
DNA Biochips—Competitive Environment
DNA Biochips—Competitive Environment (continued)
Protein Biochips for Protein Profiling, Disease Biomarkers Detection, and Protein Functions Identification
Emerging Protein Biochip Fabrication Technologies Focusing on High Sensitivity and Immobilization Efficiency
Diagnostic Protein Biochips Have High Impact on Biomarkers Discovery
Protein Biochips—Competitive Environment
Protein Biochips—Competitive Environment (continued)
Microfluidic Biochips for Disease Diagnosis at POC
Emerging Microfluidic Biochip Fabrication Technologies Focusing on High-throughput Production
Diagnostic Microfluidic Biochips Have High Impact on Identification of Nucleic Acid and Protein Biomarkers
Microfluidic Biochips—Competitive Environment
Microfluidic Biochips—Competitive Environment (continued)
Microfluidic Biochips—Competitive Environment (continued)
Microfluidic Diagnostic Biochips Segment Exhibits High Technology Evolution and Adoption Trends
Low Cost and Portability of Microfluidic Biochips Attracting Research
Microfluidics for Low-cost Multiplexing LOC Devices
Diagnostic Biochip Technology Advancing toward In Vivo Continuous Monitoring Devices
Microfluidic Biochips Excel in Portability, Cost Efficiency, and Ease of Fabrication
Recent M&A Activity Analysis, 2019–2022
Government Funding Analysis, 2019–2022
Private Funding Activities Snapshot, 2019–2022
Private Funding Activities Snapshot, 2019–2022 (continued)
Innovation Themes Include Microfluidic and Microarray Designs and Data Processing Technologies
Key Patents
Key Patents (continued)
Key Patents (continued)
Growth Opportunity 1: Molecular Electronics
Growth Opportunity 1: Molecular Electronics (continued)
Growth Opportunity 2: Micro-electrode-dot Array (MEDA) Biochips
Growth Opportunity 2: MEDA Biochips (continued)
Growth Opportunity 3: Intelligent Biochip Platform
Growth Opportunity 3: Intelligent Biochip Platform (continued)
Database of Key Industry Participants
Technology Readiness Levels (TRL): Explanation
Your Next Steps
Why Frost, Why Now?
Legal Disclaimer
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Biological systems are complex and involve several biological reactions and biomolecules. Understanding the biological reactions and identifying the biomolecules involved will help in the development of accurate diagnostics and aid precision medicine. As a large number of molecules are involved, multiple tests or bulky instruments may be required. Diagnostic biochip technology caters to the need of a miniaturized multiplexing sensing platform. A biochip is a solid substrate with a multitude of miniaturized test sites with immobilized probes that capture and detect the target biomolecules. While biochips can have several applications, the current research focuses on diagnostic biochips. There is a huge demand for precision medicine and low-cost point of care diagnostic platforms which will push the market forward. But the key players need to focus on reducing the costs of DNA and protein biochips, meeting regulatory standards and increasing awareness among users. Diagnostic biochips industry is advancing with new fluidic control technologies, probe immobilization techniques, signal detection technologies and data analytics. As they can detect all different kinds of biomolecules, the diagnostic biochip technology innovations provide growth opportunities for genetic testing, cancer diagnostics and therapy, infectious diseases management, chronic disease management, allergy panel testing and drug testing markets. The study focuses on DNA biochips, protein biochips and microfluidic biochips. The study provides an overview for the diagnostic biochips technology, their advantages and disadvantages. The drivers and restraints to the growth of the diagnostic biochips industry are discussed. The key participants in the different segments of the industry and the technologies employed are explored. The technology roadmap and the SWOT analysis of diagnostic biochips is provided. The adoption, funding and M&A trends, and the impact of the different technology segments have been analyzed. The growth opportunities for the key companies and the patent filing trend in the industry have also been put forth.
| Deliverable Type | Technology Research |
|---|---|
| Author | Sneha Maria Mariawilliam |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Podcast | No |
| WIP Number | DA60-01-00-00-00 |